Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shree Rasbihari Trading & Investment Pvt Ltd Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shree Rasbihari Trading & Investment Pvt Ltd Statement Of Investor Complaints For The Quarter Ended September 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Nikita BavishiDesignation :- Company Secretary and Compliance Officer Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shree Rasbihari Trading & Investment Pvt Ltd Shareholding for the Period Ended September 30, 2018
Mangalam Drugs & Organics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click here Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Shree Rashbihari Trading & Investment Pvt Ltd Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Mangalam Drugs & Organics Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
In accordance with the Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find herewith the details of voting results along with Scrutinizers'' Report on remote e-voting and voting through Polling papers for the 45th Annual General Meeting of the Company held on September 25, 2018. Shareholder Meeting / Postal Ballot-Outcome of AGM
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are hereby enclosing a copy of the Proceedings of the 45th Annual General Meeting of the Company which was held on 25th September, 2018 at 03.30 P.M at Kilachand Conference Room, 2nd Floor, Indian Merchants Chamber Building, IMC Marg, Churchgate, Mumbai- 400020. We request you to kindly take the above information on record and acknowledge receipt of the same. Mangalam Drugs gets final nod from WHO
Mangalam Drugs and Organics on Monday said that it recently received the final approval from World Health Organisation (WHO) for the drug Efavirenz, w